A new nonprofit wants to streamline gene therapy for diseases often avoided by pharmaceutical companies — making treatment more like a routine procedure than a bespoke drug.
‘Too Rare to Care’? A New Center for Rare Diseases Hopes to Change That
Originally reported by New York Times. Read the full story at the original source.
Related Articles
Fourth person dies in New York City legionnaires’ disease outbreak
US health officials say source of Upper East Side cluster has likely been eliminated after 76 people fell illAn outbreak...
Inside Health
Close menu Use BBC.com or the new BBC App to listen to BBC podcasts, Radio 4 and the World Service outside the UK. Play...
FDA still focused on Taylor Farms lettuce as Cyclospora source despite retracted test
Health FDA still focused on Taylor Farms lettuce as Cyclospora source despite retracted test July 21, 20264:44 AM ET ...
Trump cuts to advisory groups leaves hospitals without key expertise on disease
Health Trump cuts to advisory groups leaves hospitals without key expertise on disease July 21, 20264:44 AM ET Heard ...